Study guide

12.2 Respiratory and Lymphatic Effects

Certified Pediatric Hematology Oncology Nurse CPHON®

Track your progress as you read

Finished sections get a check mark.

1 Introduction & Exam Overview

1.1 Current Exam Facts 1.2 Eligibility, Application, and Testing Logistics 1.3 Test Content Outline and Study Strategy

2 Care Continuum

2.1 Transition of Care: Primary Care and Levels of Care 2.2 End-of-Life Care 2.3 Health Promotion and Maintenance 2.4 Survivorship

3 Leukemias and Lymphomas

3.1 Acute Lymphoblastic Leukemia 3.2 Acute Myeloid Leukemia and Related Myeloid Disease 3.3 Hodgkin and Non-Hodgkin Lymphomas

4 CNS, Neuroblastoma, and Renal Tumors

4.1 Central Nervous System Tumors 4.2 Neuroblastoma 4.3 Wilms Tumor and Other Renal Tumors

5 Sarcomas and Other Solid Tumors

5.1 Osteosarcoma and Ewing Sarcoma 5.2 Rhabdomyosarcoma and Soft-Tissue Sarcomas 5.3 Retinoblastoma, Hepatoblastoma, and Germ Cell Tumors

6 Hematologic Disorders

6.1 Sickle Cell Disease 6.2 Thalassemia and Other Hemoglobinopathies 6.3 Hemophilia, von Willebrand Disease, and Coagulopathies 6.4 Immune Thrombocytopenia, Aplastic Anemia, and Bone Marrow Failure

7 Pathophysiology, Genetics, and Diagnostics

7.1 Anatomy, Physiology, and Pathophysiology Foundations 7.2 Genetics and Genomics 7.3 Diagnostic Testing, Staging, and Prognosis

8 Clinical Trials and Professional Performance

8.1 Clinical Trials and Informed Consent 8.2 Scope, Standards, and Regulatory Practice 8.3 Ethics and Patient-Family Education

9 Chemotherapy and Biotherapy

9.1 Chemotherapy Principles, Classes, and Pediatric Protocols 9.2 Safe Handling, Administration, and Vesicant Precautions 9.3 Biotherapy

10 Immunotherapy, Cellular Therapy, and Radiation

10.1 Immunotherapy 10.2 Cellular Therapies including CAR-T 10.3 Radiation Therapy, I-131-MIBG, and Proton Beam

11 HSCT, Surgery, Transfusion, and Coagulation Therapy

11.1 Hematopoietic Stem Cell Transplantation 11.2 Surgical Management 11.3 Blood Product Therapy, Leukapheresis, and Coagulation Therapy

12 Neurologic, Respiratory, and Cardiovascular Effects

12.1 Neurological Acute, Chronic, and Late Effects 12.2 Respiratory and Lymphatic Effects 12.3 Cardiovascular Effects

13 Gastrointestinal, Renal, Musculoskeletal, and Integumentary Effects

13.1 Gastrointestinal Effects 13.2 Renal and Genitourinary Effects 13.3 Musculoskeletal and Integumentary Effects

14 Endocrine, Hematologic, Immunologic, and Sensory Effects

14.1 Endocrine and Reproductive Effects 14.2 Hematological and Immunological Effects 14.3 Ophthalmological and Otological Effects

15 Pain, Sleep, Fatigue, and Mental Health

15.1 Pain Assessment and Management 15.2 Sleep Disturbance and Fatigue 15.3 Mental Health Effects

16 Supportive Care

16.1 Medical Devices: Venous Access, Pumps, Shunts, and Tubes 16.2 Blood Product Administration 16.3 Colony-Stimulating Factors 16.4 Interdisciplinary, Palliative, and Complementary Care

17 Infectious and Gastrointestinal Emergencies

17.1 Sepsis 17.2 Typhlitis 17.3 Pancreatitis and Bowel Obstruction

18 Metabolic Emergencies

18.1 Diabetes Insipidus and SIADH 18.2 Tumor Lysis Syndrome 18.3 Cytokine Release Syndrome

19 DIC, Hyperleukocytosis, and Sinusoidal Obstructive Syndrome

19.1 Disseminated Intravascular Coagulation and Hemorrhage 19.2 Hyperleukocytosis 19.3 Sinusoidal Obstructive Syndrome (Veno-Occlusive Disease)

20 Sickle Cell and Hemostasis Emergencies

20.1 Splenic Sequestration 20.2 Vaso-Occlusive Crisis 20.3 Stroke, Thrombosis, and Joint Bleed

21 Cardiopulmonary Emergencies

21.1 Acute Chest Syndrome 21.2 Respiratory Distress and Mediastinal Mass 21.3 Pleural Effusions and Arrhythmias

22 Neurologic and Infusion Emergencies

22.1 Increased Intracranial Pressure 22.2 Seizures and PRES 22.3 Spinal Cord Compression 22.4 Hypersensitivity Reactions and Extravasation

23 Family, Caregivers, and Social Integration

23.1 Effects of Acute and Chronic Illness on Patient and Family 23.2 Patient and Family/Caregiver Support 23.3 Integration into Family, School, Work, Camp, and Social Environment

24 Development, Grief, Culture, and Community Resources

24.1 Principles of Growth and Development 24.2 Grief and Bereavement 24.3 Culture, Sexuality and Gender, Socioeconomics, and Community Resources

12.2 Respiratory and Lymphatic Effects

Key Takeaways Explain This Topic AI

Bleomycin pulmonary toxicity is a dry cough, dyspnea, falling diffusing capacity, and hypoxia; hold bleomycin, use the lowest oxygen fraction that meets saturation goals, and obtain pulmonary function tests as ordered.

Radiation pneumonitis (often one to three months after chest radiation) can progress to fibrosis; it is not distinguished from Pneumocystis, viral, or fungal pneumonia by history alone—work up infection before labeling drug or radiation injury.

Immunocompromised children are at high risk for respiratory syncytial virus (RSV), influenza, and Pneumocystis jirovecii pneumonia; keep trimethoprim-sulfamethoxazole prophylaxis on indicated protocols and teach household inactivated influenza vaccine plus stay-home-if-ill rules.

Chronic graft-versus-host disease can produce bronchiolitis obliterans: new obstructive pulmonary function tests after allogeneic transplant, not ordinary asthma.

Lymphedema follows node dissection or nodal radiation; chylous (milky, triglyceride-rich) effusion follows thoracic-duct injury. Pulse oximetry, play-based incentive spirometry, oxygen, and activity as tolerated are the daily respiratory toolkit. Transfusion-associated circulatory overload and transfusion-related acute lung injury are signposted, not restated.

Last updated: August 2026

TCO IV.A.2 and IV.A.14 test respiratory and lymphatic treatment effects: what the drug, the beam, the transplant, the node dissection, or the thoracic duct did to gas exchange and lymph flow. This is not the emergency chapter for acute chest syndrome , mediastinal airway compression, or the full transfusion-associated circulatory overload (TACO) and transfusion-related acute lung injury (TRALI) algorithms. Those are signposted. Here the CPHON nurse watches pulse oximetry , work of breathing, and a child's ability to play, then decides whether the next move is holding bleomycin , starting an infection workup, teaching the household to stay home with influenza, or elevating a swollen limb.

A 16-year-old with Hodgkin lymphoma who develops a dry cough on bleomycin, a 3-year-old on delayed intensification with a winter runny-nose exposure, and an 8-year-old after thoracic neuroblastoma resection with milky chest-tube output are the pictures.

Bleomycin and radiation lung injury

Bleomycin is used on some Hodgkin and germ-cell pathways. Pulmonary toxicity may appear during therapy or months later. The child has a dry cough , dyspnea, crackles, fever, or a falling saturation. Pulmonary function tests (PFTs) , especially diffusing capacity of the lung for carbon monoxide (DLCO) , trend before and during treatment on many protocols. A declining DLCO plus new symptoms is a hold, not a "push through this cycle" moment. Use the lowest fraction of inspired oxygen (FiO2) that meets ordered saturation goals; unnecessary high FiO2 can potentiate bleomycin lung injury. Corticosteroids are used for pneumonitis as ordered. Late fibrosis is a chronic restrictive disease: activity limits follow pulmonology, not a coach's pep talk.

Radiation pneumonitis typically declares about one to three months after chest radiation—Hodgkin involved-site fields, whole-lung treatment for metastases (Wilms tumor, Ewing sarcoma, rhabdomyosarcoma), or total body irradiation (TBI) before transplant. Fever, dry cough, dyspnea, and an infiltrate that respects the radiation field are the clues. Radiation fibrosis follows months to years later as a restrictive defect and, in severe cases, chronic oxygen need. Symptomatic pneumonitis is treated with corticosteroids as ordered after infection is addressed. Do not invent a single gray threshold as an ONCC number; teach field, timing, and the workup.

Infection, pneumonitis, and why the workup is the nursing plan

Pneumonitis versus infection is a differential, not a guess. Bleomycin injury, radiation pneumonitis, Pneumocystis jirovecii pneumonia (PJP) , respiratory viruses, and fungi can share fever, hypoxia, and interstitial markings. The CPHON action is a workup : pulse oximetry, chest imaging as ordered, respiratory viral testing, and a low threshold to involve the infectious-disease and pulmonary teams—not a solo decision that "this is just radiation."

Immunocompromised children—ALL delayed intensification, infants, hematopoietic stem cell transplant (HSCT) recipients—are at high risk for respiratory syncytial virus (RSV) , influenza , and PJP . Trimethoprim-sulfamethoxazole prophylaxis on ALL and HSCT pathways exists because PJP is preventable; missed doses are a nursing failure, not a trivia fact. Breakthrough PJP presents with subacute dyspnea, hypoxia, and fever. RSV in a 2-year-old after transplant can progress from a "cold" to respiratory failure; isolate, support oxygen, and treat the infant's work of breathing as real. Influenza is a household problem: inactivated influenza vaccine for contacts, and for the child when the oncology team clears counts. Live attenuated nasal influenza vaccine is not the default for the immunosuppressed patient. Teach stay-home-if-ill rules for siblings and visitors. School influenza clinics do not vaccinate the oncology patient without oncology clearance—the same principle as in transition-of-care teaching.

Bronchiolitis obliterans, transfusion lung injury, and daily pulmonary nursing

After allogeneic HSCT , chronic graft-versus-host disease (GVHD) can produce bronchiolitis obliterans : new obstructive PFTs, air trapping, wheeze or dyspnea that does not behave like ordinary reversible asthma. Surveillance PFTs belong on the post-transplant calendar. Infection prevention, pulmonary rehabilitation as ordered, and HSCT-team immunosuppression changes are the disease-modifying path. Do not endlessly escalate albuterol at home without telling the transplant clinic.

TACO (hydrostatic overload, often hypertensive, may improve with diuresis) and TRALI (inflammatory acute lung injury during or after transfusion) are signposted . Stop the product, support oxygen, notify the blood bank and the team, and do not finish the unit to "see if the cough settles." Full emergency titration lives later. Acute chest syndrome in sickle cell disease is likewise a later cardiopulmonary-emergency section; a new infiltrate plus respiratory symptoms in a child with hemoglobin SS is not bleomycin toxicity.

Daily tools are simple and pediatric: continuous or frequent pulse oximetry when hypoxic or at risk, play-based incentive spirometry (bubbles, pinwheels, party blowers for toddlers; a spirometer for school-age children), pulmonary hygiene, oxygen as ordered, and activity as tolerated to prevent atelectasis. A 5-year-old after chest radiation who will not "do spirometry" will often blow bubbles with a parent. That is still the intervention.

  • Syndrome Typical clue Nursing move
  • Bleomycin toxicity Dry cough, falling DLCO, hypoxia Hold bleomycin; avoid extra high FiO2

Radiation pneumonitis Field-shaped infiltrate ~1–3 months after chest RT Steroids as ordered after infection workup

  • Radiation fibrosis Late restrictive disease Rehab, oxygen if chronic
  • PJP Breakthrough if prophylaxis missed Trimethoprim-sulfamethoxazole adherence; treat as infection
  • RSV or influenza Season, household exposure Isolation, oxygen, household inactivated vaccine
  • Bronchiolitis obliterans Post-allo HSCT obstructive PFTs Not ordinary asthma; notify HSCT team
  • TACO or TRALI During or after transfusion Stop product; emergency chapter
  • Lymphedema After nodal surgery or radiation Skin care; avoid blood pressure cuffs on that limb when feasible
  • Chylous effusion Milky chest-tube output after thoracic surgery Respiratory support; diet as ordered
  • Lymphatic effects: lymphedema and chyle

Lymphedema follows lymph-node dissection (groin or axillary beds in extremity sarcoma, selected other solid tumors) and nodal radiation . The limb swells, skin breaks down, and cellulitis becomes an emergency for that extremity. Teach elevation, skin care, and referral to physical therapy or a lymphedema clinic. Avoid blood-pressure cuffs, venipuncture, and intravenous lines on the affected limb when another site is available. Compression garments are used as ordered, not improvised with an elastic bandage at home.

Chylous effusion follows thoracic-duct injury during chest or mediastinal surgery—thoracic neuroblastoma, mediastinal germ-cell or lymphoma resection, selected central-line or thoracotomy complications. Output is milky and triglyceride-rich . Respiratory compromise is treated first: oxygen, positioning, chest-tube care. Nutrition is a low-long-chain-fat or medium-chain-triglyceride plan, parenteral nutrition, and sometimes octreotide as ordered; surgical ligation is a team decision if leak persists. Do not call milky output "ordinary serous drainage" and strip the tube harder.

The CPHON product is a child whose cough is worked up, whose bleomycin is held when the lung is the organ failing, whose household is vaccinated and stays home when sick, and whose swollen arm or milky chest tube is treated as lymphatic injury rather than ignored edema.

Loading diagram... Respiratory and lymphatic effects: workup first, then the named injury